2019
DOI: 10.3389/fimmu.2019.02087
|View full text |Cite
|
Sign up to set email alerts
|

NK Cell IL-10 Production Requires IL-15 and IL-10 Driven STAT3 Activation

Abstract: Natural killer (NK) cells can produce IFNγ or IL-10 to regulate inflammation and immune responses but the factors driving NK cell IL-10 secretion are poorly-defined. Here, we identified NK cell-intrinsic STAT3 activation as vital for IL-10 production during both systemic Listeria monocytogenes (Lm) infection and following IL-15 cytokine/receptor complex (IL15C) treatment for experimental cerebral malaria (ECM). In both contexts, conditional Stat3 deficiency in NK cells abrogated production of IL-10. Initial NK… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 78 publications
0
21
0
Order By: Relevance
“…It has been determined that STAT3 activation is closely related to the production of IL-10 (51-53). Whether IL-15C treatment or during systemic Lm infection, NKSTAT3mice do not produce IL-10 efficiently, and there is ample evidence that serum IL-10 levels in NKSTAT3mice are similar to those in B6.IL-10 -/mice despite Lm infection (35). Similarly, in NK-tumor cocultures, low-dose GPB730 (selective STAT3 inhibitor) pretreatment of NK cells can also inhibit the production of IL-10 (15).…”
Section: Transcription Factors That Regulate Il-10 Producing Nk Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been determined that STAT3 activation is closely related to the production of IL-10 (51-53). Whether IL-15C treatment or during systemic Lm infection, NKSTAT3mice do not produce IL-10 efficiently, and there is ample evidence that serum IL-10 levels in NKSTAT3mice are similar to those in B6.IL-10 -/mice despite Lm infection (35). Similarly, in NK-tumor cocultures, low-dose GPB730 (selective STAT3 inhibitor) pretreatment of NK cells can also inhibit the production of IL-10 (15).…”
Section: Transcription Factors That Regulate Il-10 Producing Nk Cellsmentioning
confidence: 99%
“…Among them, IL-15 has attracted much attention due to its therapeutic potential in cancer ( 33 , 34 ). Recently, in murine models of Lm infection and experimental cerebral malaria (ILM), it was reported that IL-15 cytokine/receptor complex (IL15C) produces IL-10 by driving STAT3 phosphorylation in NK cells ( 26 , 35 ) ( Figure 1 ). Specifically, STAT3 signal transduction and NK cells IL-10 production are detrimental to host innate resistance to Lm, but may contribute to the survival of cerebral malaria models.…”
Section: Molecular Mechanisms Controlling Il-10 Expression In Ilcsmentioning
confidence: 99%
“…Thus, the anti-inflammatory cytokine, IL-1RA, seems to be a reliable and suitable marker which reflect the physiological exercise response and recovery processes in athletes’ during endurance exercises. IL-10 is primarily expressed by monocytes and represents an anti-inflammatory cytokine, while IL-15 is a regulator of the activity of T cells and natural killer cells 26 . Limitations in the methodological analysis of IL-10 and IL-15 are suggested to be the reason for the weak reliabilities within these cytokines.…”
Section: Discussionmentioning
confidence: 99%
“…We agree with Dr Hydes and Prof. Khakoo on the relevance of NK cells in bridging innate with adaptive immunity in PBC, with one characteristic being enhanced interferon (IFN)-c, other than IL-10, production. 4,5 In particular, NK cell cytotoxicity against biliary epithelial cells (BECs) is initiated only after toll-like receptor (TLR) 3-mediated NK stimulation and TLR4-mediated monocyte stimulation. This function is regulated by a large family of inhibitory NK cell receptors, including killer-cell immunoglobulin-like receptors and C-lectin type molecules, which recognize major histocompatibility complex (MHC) class I present on autologous cells.…”
Section: To the Editormentioning
confidence: 99%